Genenta Science S.p.A.

NasdaqCM:GNTA Stock Report

Market Cap: US$84.7m

Genenta Science Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Pierluigi Paracchi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure11yrs
CEO ownership12.6%
Management average tenure3.7yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

We're Keeping An Eye On Genenta Science's (NASDAQ:GNTA) Cash Burn Rate

Jan 26
We're Keeping An Eye On Genenta Science's (NASDAQ:GNTA) Cash Burn Rate

We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely

Jul 21
We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely

We're Not Worried About Genenta Science's (NASDAQ:GNTA) Cash Burn

Dec 10
We're Not Worried About Genenta Science's (NASDAQ:GNTA) Cash Burn

We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely

Sep 09
We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely

Gene therapy developer Genenta Science named a buy at Wainwright on tumor approach

Jul 25

Is Genenta Science (NASDAQ:GNTA) In A Good Position To Invest In Growth?

Mar 18
Is Genenta Science (NASDAQ:GNTA) In A Good Position To Invest In Growth?

CEO

Pierluigi Paracchi (51 yo)

11yrs

Tenure

Mr. Pierluigi Paracchi, DEc, is Co-Founder of Genenta Science S.p.A., serves as its Chief Executive Officer and was its General Manager and served as its Chairman until November 2020 and was its Vice Chair...

Leadership Team

NamePositionTenureCompensationOwnership
Pierluigi Paracchi
Co-Founderno datano data12.56%
$ 10.6m
Luigi Naldini
Co-Founder & Chairman of the Executive Scientific Boardno datano data7.58%
$ 6.4m
Bernard Gentner
Co-Founder & Member of the Executive Scientific Boardno datano data3.79%
$ 3.2m
Richard Slansky
Chief Financial Officer3.7yrsno data0.11%
$ 92.4k
Carlo Russo
Chief Medical Officer & Head of Development3.7yrsno data3.27%
$ 2.8m
Stefania Mazzoleni
Director of Program Development2yrsno data0.17%
$ 140.4k
Barbara Regonini
Director of Finance4yrsno data0%
$ 0

3.7yrs

Average Tenure

51yo

Average Age

Experienced Management: GNTA's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Pierluigi Paracchi
Co-Founder11yrsno data12.56%
$ 10.6m
Luigi Naldini
Co-Founder & Chairman of the Executive Scientific Boardno datano data7.58%
$ 6.4m
Bernard Gentner
Co-Founder & Member of the Executive Scientific Boardno datano data3.79%
$ 3.2m
Kenneth Anderson
Member of Scientific Advisory Boardno datano datano data
Richard Flavell
Member of Scientific Advisory Board3.7yrsno datano data
Patrick Wen
Member of Scientific Advisory Board3.7yrsno datano data
Miriam Merad
Member of Scientific Advisory Board3.7yrsno datano data
Wolf-Herve Fridman
Member of Scientific Advisory Board3.7yrsno datano data
Michele De Palma
Member of Scientific Advisory Boardno datano datano data
Haeyong Chung
Directorless than a yearno datano data
Lisa Coussens
Member of Scientific Advisory Boardno datano datano data
Carlo-Alberto Nicchio
Chairman of the Board of Statutory Auditors3.7yrsno datano data

3.7yrs

Average Tenure

51yo

Average Age

Experienced Board: GNTA's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 06:18
End of Day Share Price 2025/01/07 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genenta Science S.p.A. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph PantginisH.C. Wainwright & Co.
Emanuela BranchettiH.C. Wainwright & Co.
Jason McCarthyMaxim Group